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Abstract
Background: The thickness of fibrous caps (FCT) of atherosclerotic lesions is a critical factor affecting plaque
vulnerability to rupture. This study tests whether 3 Tesla high-resolution intravascular cardiovascular magnetic
resonance (CMR) employing tiny loopless detectors can identify lesions and accurately measure FCT in human
arterial specimens, and whether such an approach is feasible in vivo using animal models.
Methods: Receive-only 2.2 mm and 0.8 mm diameter intravascular loopless CMR detectors were fabricated for a
clinical 3 Tesla MR scanner, and the absolute signal-to-noise ratio determined. The detectors were applied in a two-
step protocol comprised of CMR angiography to identify atherosclerotic lesions, followed by high-resolution CMR
to characterize FCT, lesion size, and/or vessel wall thickness. The protocol was applied in fresh human iliac and
carotid artery specimens in a human-equivalent saline bath. Mean FCT measured by 80 μm intravascular CMR was
compared with histology of the same sections. In vivo studies compared aortic wall thickness and plaque size in
healthy and hyperlipidemic rabbit models, with post-mortem histology.
Results: Histology confirmed plaques in human specimens, with calcifications appearing as signal voids. Mean FCT
agreed with histological measurements within 13% on average (correlation coefficient, R = 0.98; Bland-Altman
analysis, -1.3 ± 68.9 μm). In vivo aortic wall and plaque size measured by 80 μm intravascular CMR agreed with
histology.
Conclusion: Intravascular 3T CMR with loopless detectors can both locate atherosclerotic lesions, and accurately
measure FCT at high-resolution in a strategy that appears feasible in vivo. The approach shows promise for
quantifying vulnerable plaque for evaluating experimental therapies.
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Background
Atherosclerosis is characterized in its advanced stages by
lesions containing extra-cellular lipids, foam cells and/or
calcium deposits in the arterial wall, covered by fibrous
caps [1-3]. Its clinical symptoms often involve progressive
myocardial, cerebral or peripheral ischemia resulting from
the ensuing stenosis, but lesion rupture can cause acute
thrombosis, stroke, heart attack and death [1-5]. Fibrous
cap thickness (FCT) is an important factor in determining
the vulnerability of atherosclerotic plaques. Because thin
caps are associated with large plaque stress and the likeli-
hood of rupture [3-6], an ability to accurately quantify
FCT in situ could prove key to identifying plaques that are
most vulnerable to rupture and would benefit most from
intervention, as well as evaluating the mechanistic and
morphological changes responsive to therapies aimed at
plaque regression.
While an FCT of less than 65 μm has been used to
classify fibrous caps in coronary plaques as vulnerable
[7-10], currently there isn’t an accepted clinical metho-
dology for identifying unstable plaques in patients in situ
[11]. X-ray angiography routinely detects stenoses by
imaging the arterial lumen, but not the vessel wall or
lesion morphology per se, nor early-stage lesions with
mild-to-moderate stenoses [5]. Intravascular ultrasound
(IVUS) can provide trans-luminal imaging at ≥100 μm
resolution without ionizing radiation [9,11,12], although
it is typically performed during withdrawal of an imaging
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catheter threaded over a guidewire inserted under X-ray
fluoroscopy [13]. IVUS studies of human endarterectomy
specimens suggest that an FCT threshold of 650 μm can
discriminate symptomatic from asymptomatic carotid
artery stenoses [14]. Optical coherence tomography
(OCT) is another intravascular imaging option [15] that
is fast, has high resolution (10-20 μm), but a limited
penetration depth of about 1 mm [9,10,15,16]. It also
requires a blood-free environment, afforded by intermit-
tent saline flushes through an X-ray fluoroscopic guide
catheter [9,10].
Cardiovascular magnetic resonance (CMR) offers the
multi-functionality and intrinsically high soft-tissue con-
trast that could potentially add unique value and provide
intravascular imaging without X-ray guidance or ionizing
radiation [17-20]. However, when applied noninvasively
with external detector coils, CMR’s spatial resolution for
differentiating FCT is more limited (> 200 μm) than both
IVUS and OCT [17-20]. To improve local sensitivity and
spatial resolution, intravascular CMR employing tiny
detectors as guidewires or catheters was proposed many
years ago [21-26]. At clinical field strengths of B0 = 1.5
Tesla (T), these devices have demonstrated efficacy in
characterizing vessel wall thickness and plaque compo-
nents in larger vessels with in-plane resolution ≥100 μm
[27-30]. Nevertheless, as emphasized in recent editorials,
the speed and spatial resolution of intravascular CMR
remain a challenge [31,32]. A resolution of 80 μm or bet-
ter may be needed to resolve plaque components in smal-
ler critical vessels, and at this time it is not known
whether an intravascular CMR modality will ever be a
practical tool for plaque characterization or FCT measure-
ments in patients [31].
Yet the recent emergence of clinical 3T MR scanners
does afford some new opportunity for addressing these
problems by virtue of an almost quadratic gain in signal-
to-noise ratio (SNR) with B0, due to the intrinsic noise
properties of tiny detectors [33,34]. As a consequence,
“loopless antenna” detectors [25] realizing a ~4-fold higher
SNR and a ~10-fold increase in visual field-of-view (FOV)
at 3 T compared to the original 1.5 T detectors, have been
demonstrated [33]. This, with local heating controlled at
≤1°C [33]. In the present study, we investigate whether
such 1-2 mm diameter detect-only 3 T intravascular
antenna guidewires can both identify atherosclerotic
lesions without X-ray fluoroscopic guidance, and provide
high-resolution (< 100 μm) imaging of vessel anatomy and
accurate FCT and wall thickness measurements in a con-
ventional clinical 3T MR scanner. FCT is measured at
80 μm resolution in diseased human arterial specimens in
vitro, and the results compared with histology. The feasi-
bility of the approach is then demonstrated in vivo in
healthy and hyperlipidemic rabbit aortas, a vessel that is
comparable in size to a human coronary.
Methods
Devices
In vitro CMR studies were performed with a 3T loopless
“receive-only” detector fabricated from a UT-85C (outer
diameter, OD = 2.2 mm) semi-rigid copper coaxial cable
(Micro-coax, Inc., Pottstown, PA) to fit within the
approximately 8 - 15 mm lumens of human vessel speci-
mens studied (Figure 1). The length of the detector’s
coaxial cable was tuned to a quarter-wavelength (l/4 ≈
40 cm). The central conductor was extended an addi-
tional 4 cm beyond the cable portion to form a whip that
maximized signal at the whip-cable junction [33]. The
outer surface of the cable was insulated with 0.02 mm
polyester (dielectric constant, ε = 3) heat-shrink tubing
(Advanced Polymer Inc, Salem, NH). To determine its
sensitivity in the plane of the cable for angiography and/
or tracking, the absolute SNR of the device in a 0.35%
Figure 1 Photograph of semi-rigid, 40-cm cable-length,
loopless CMR detector used for in vitro studies (left), and its
absolute SNR distribution (in ml-1Hz1/2; contours and color-
coded at right) on a one-sided plane along its length. Distances
are in mm with the probe oriented parallel to the main magnetic
field (z-axis). The SNR is cylindrically symmetric about the long axis.
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saline phantom with radio-frequency (RF) electrical prop-
erties comparable to those of tissue (conductivity, s = 0.6
S/m, dielectric constant ε = 80) was determined by the
numerical method-of-moments (FEKO EM analysis soft-
ware, Stellenbosch, South Africa) from the ratio of the
circularly polarized RF field excited by a 1A current, to
the square root of the antenna resistance in the saline
[33]. Since the SNR is cylindrically symmetric about the
cable’s long axis, the computation was performed on a
single plane on one side of the detector, over the range
0.1 ≤ r ≤40 mm from the detector outer conductor, and
0 ≤ z ≤39 cm from the detector tip, as well as in axial
planes about the detector junction.
In vivo experiments were performed with a biocompati-
ble nitinol loopless imaging detector (Figure 2) with the
same coaxial structure as the detector used for the in vitro
experiments. It was formed by modifying an obsolete
0.76 mm OD Intercept 1.5T guidewire (MRI Interventions,
formerly Surgi-Vision Inc, Memphis TN) for 3T use by
retuning the whip to 40 mm, and extending the cable
length to 3l/4 (for a total cable length of 120 cm) to per-
mit practical in vivo use in the magnet bore. Device heat-
ing during CMR was controlled at ≤1°C with decoupling
circuitry described previously, and demonstrated in safety
studies on a saline gel phantom [33]. The detector was
tuned, matched, and interfaced to a 3T Philips Achieva
MR scanner equipped with an X-ray C-arm (Philips
Healthcare, Cleveland, OH) [33].
In vitro Studies
The 3T loopless CMR detector was first used to identify
suspected plaques inside a fresh ~10 cm-long human
iliac artery specimen, complete with bifurcation, har-
vested at autopsy within 3 hours of death. All studies of
decedent specimens were approved by this institution’s
Office of Human Subject Research, Institutional Review
Board. The vessel was secured to a plastic frame inside
a 0.35% saline phantom (with s = 0.6 S/m, ε = 80). The
3T detector was inserted into the lumen, and a spin-lat-
tice relaxation time (T1)-weighted angiographic scan
performed in the coronal plane along the luminal long-
axis (three-dimensional fast field echo, 3D FFE; FOV =
120 x73 mm; resolution, 0.5 x0.5 x1 mm; array size =
256 × 256 × 10; repetition time/echo time, TR/TE = 25/
2.6 ms; flip-angle, FA = 20°; scan time = 143 s). After
locating suspected plaques on the coronal angiographic
scans, high-resolution trans-axial spin-spin relaxation time
(T2)-weighted scanning of the vessel wall was performed
(3D turbo spin-echo, TSE factor = 9; FOV = 20 × 20 mm;
TR/TE = 1500/32 ms; resolution = 80 μm × 80 μm ×
2 mm; FA = 90°; 4 averages; scan time = 1514 s) to reveal
the fibrous cap. To determine the effect of image resolu-
tion on measurements of FCT, the same section of a
human iliac specimen was imaged with the same sequence
but at 80, 100 and 140 μm in-plane resolution.
The locations of the high-resolution trans-axial images
were registered to the vessels by first measuring their dis-
tance to the ends of the vessels as visualized on the coro-
nal images. After CMR, vessels were decalcified for 48 hrs
and cut into 5-10 mm sections, each facing the location of
the corresponding trans-axial image to the nearest milli-
meter. The histological sections were visually inspected for
antenna-related injury to the vessel wall, embedded in
wax, microtomed, and stained with hematoxylin and eosin
(H&E) at this institution’s pathology service. The sections
were then photographed with a microscope-mounted digi-
tal camera.
To test whether high-resolution 3T interventional CMR
with a loopless detector could be used to provide accurate
measures of FCT, thirty-one diseased carotid artery seg-
ments with atherosclerotic lesions identified by palpation,
were harvested from sixteen adult human cadavers. These
vessel segments were fixed in 10% formalin at 3°C for
24 hr. High resolution T2-weighted CMR of the vessel
wall was performed on vessels mounted in the saline
phantom, followed by sectioning and histology as
described above.
The FCT was measured in both the CMR and the histol-
ogy sections between the two shoulder ends of the fibrous
cap at an interval of 480 μm, or at about every 6 pixels in
the 80 μm CMR. Distance was measured in histology sec-
tions using a movable scale overlaid on the digital micro-
graph, and in CMR by counting pixels and multiplying by
the resolution. Measurements were restricted only to the
regions with clear fibrous cap and lumen borders. The
average of all of the FCT measurements from each image
Figure 2 Photograph of the biocompatible 3T loopless CMR
detector. The components are: (1) BNC connection to the MR
scanner interface; (2) tuning, matching, and decoupling circuit box;
(3) coaxial extension cable; (4) coaxial cable from an obsolete 1.5T
Intercept guidewire (OD = 0.76 mm); and (5) the extended inner
conductor whip (length = 4 cm).
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was recorded as the mean FCT for that image section. The
mean FCT for the iliac specimen imaged at 80, 100 and
140 μm resolution was measured the same way.
In vivo Studies
High-resolution intravascular CMR was performed in
vivo using the 3T biocompatible loopless detector in a
healthy adult New Zealand white rabbit, and a 30-month
old male Watanabe heritable hyper-lipidemic (WHHL)
rabbit which is prone to spontaneously develop athero-
sclerotic lesions. The study was approved by this institu-
tion’s Animal Care and Use Committee. The animals
were sedated and positioned supine in the 3T scanner,
and the detector inserted into the aorta via the femoral
artery and a 5-French introducer under CMR guidance.
The same T1-weighted angiographic coronal scan as in
the in vitro studies was used, except that the scans were
cardiac-triggered. The location of the detector’s junction
in the animal relative to the renal bifurcation was deter-
mined by X-ray fluoroscopy and on the coronal T1 angio-
graphic images. The locations of the high-resolution
trans-axial images relative to the detector’s junction and
to the center of the renal bifurcation were noted for sub-
sequent co-registration.
High-resolution trans-axial CMR of the aortic wall was
performed above the renal bifurcation. A T2-weighted TSE
sequence modified for black-blood with cardiac gating was
used for the healthy rabbit (FOV = 80 × 40 mm; TR/TE =
3000/21 ms; resolution = 80 μm × 80 μm × 3 mm; array
size = 1008 × 1008; FA: 90°; 4 averages; scan time = 597 s),
and a 3D T1 weighted TSE black-blood sequence with
shortened scan-time was used for the hyperlipidemic rabbit
(FOV = 20 x10 mm, TR/TE = 429/26; resolution = 80 μm
× 80 μm × 2 mm; array size = 256 × 256 × 10; FA: 90°;
8 averages; scan time = 436 s). After CMR, the rabbits
were humanely sacrificed. The aortas were harvested and
cut into 5 mm sections facing the locations at which trans-
axial CMR was performed, referenced relative to the renal
bifurcation. The sections were visually inspected for injury,
then H&E stained for histology as above.
Results
In vitro Studies
The computed absolute SNR distribution of the loopless
detector is shown in Figure 1. The highest SNR occurs at
the detector’s whip-cable junction at a radial distance r =
0.1 mm, falling to 17% of the peak at r = 5 mm. However,
excluding the tip [35], the absolute SNR of the device for
small r is preserved to at least half of the peak value over
an extended region in the longitudinal plane for distances
z ≤80 mm from the device junction.
Figure 3 exemplifies T1-weighted angiographic scout
CMR, and high-resolution trans-axial images acquired
from human iliac artery specimens in vitro. In coronal
angiographic images, calcified plaques appeared as
regions of low intensity or signal voids, such as those
between the vessel walls below the iliac bifurcation in
Figure 3(A). The guide-wire CMR detector itself con-
tains no mobile protons and also appears as a signal
void: the absence of any image decoupling artifact
around the probe attests to the efficacy of the tune/
match/decoupling circuitry [33,35]. The extended region
of sensitivity permits high-resolution imaging virtually
anywhere in these lesions, and the trans-axial 80 μm
image of the iliac vessel wall (Figure 3B) reveals a calci-
fied plaque as a void separated from the fluid-filled
lumen by the fibrous cap. The vessel wall morphology is
confirmed by microscopy of the corresponding histolo-
gical section (Figure 3C).
CMR of a human iliac vessel acquired at 80, 100, and
140 μm resolution is presented in Figure 4 with corre-
sponding histology. Mean FCT was 360, 243, and 206
μm, when measured with 140, 100, and 80 μm resolution
intravascular CMR, respectively (Figure 4A-C). Mean
FCT from histology was lower at 186 μm (Figure 4D),
consistent with the view that reducing the CMR spatial
resolution (increasing voxel size) decreases the accuracy
of FCT measurements.
All 31 vessel segments exhibited lesions with fibrous
caps based on histology. High-resolution CMR of carotid
vessel walls at 80 μm also revealed atheroma in all vessel
segments, permitting 3-13 individual FCT measurements
from each CMR section, and 3-12 FCT measurements in
each of the corresponding histological sections, from
which the mean FCT was determined. The mean FCT
measured from CMR is plotted against the mean FCT
from histology in Figure 5. The mean FCT by histology
ranged from 74 μm to 1.1 mm. The two sets of measure-
ments are highly correlated (correlation coefficient, R =
0.96). Even limiting the data to those samples with mean
FCT < 650 μm (24 out of 31 samples) as measured by his-
tology, preserves the correlation (y = 0.921x + 29.8, R =
0.91, P = 0.98). Bland-Altman analysis (Figure 6) shows
excellent agreement between the FCT measured by CMR
and that measured by histology (-1.3 ± 68.9 μm).
In vivo Studies
The placement of a biocompatible 3T loopless detector in
the New Zealand White rabbit aorta in vivo under CMR
angiography is exemplified in Figure 7(A). This shows the
detector’s whip-cable junction where signal intensity is
highest (Figure 1), 4 cm above the renal bifurcation. Unlike
CMR endoscopic probes [33,34], the receive-only intravas-
cular detector used here reveals the entire aorta and some
adjacent anatomical structures, including the renal bifurca-
tion. X-ray fluoroscopy confirmed the location of the
whip-cable junction 4 cm above the renal-bifurcation (Fig-
ure 7B). An 80 μm trans-axial high-resolution CMR of the
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aorta delineates the vessel wall in the rabbit (Figure 7C).
The vessel wall thickness was measured from the image at
12 equi-angular locations around the vessel, commencing
at a vessel feature identifiable on both CMR and histologi-
cal images (solid arrows, Figure 7C, D). The average wall
thickness from high-resolution intravascular 3T CMR was
0.54 mm ± 0.06 (SD) (Figure 7C), in agreement with an
average thickness of 0.55 ± 0.07 mm measured the same
way in the histological section (Figure 7D).
In the hyperlipidemic rabbit, in vivo 80 μm high-reso-
lution T1-weighted CMR revealed a region of elevated
signal intensity on the inner wall of the vessel extending
Figure 3 (A) T1-weighted angiographic coronal image of a human iliac artery specimen in vitro showing calcified plaque inside vessel
wall (3 parallel arrows, center). The detector’s cable appears dark, with a bright signal surrounding the narrower whip. (B) High resolution
intravascular 3 T CMR of the vessel wall cross section showing calcified plaque (yellow arrow), fibrous cap (red arrows) and the circular cross-
section of the detector (white arrow). (C) Histological image of the iliac artery vessel wall showing calcified plaque (yellow arrow) and fibrous
cap (red arrows).
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into the lumen (Figure 8A, B), consistent with a pattern
of fibrous atheroma tissue [29]. A small atherosclerotic
lesion was confirmed in the corresponding histological
section from the same location (Figure 8C). This shows
a fairly homogeneous layer of fibrous tissue, with a
higher lipid content rendering it paler than the adventi-
tia. The area of the plaque region measured from CMR
(Figure 8B) is 0.36 mm2, while the plaque area in the
histological section is 0.33 mm2.
Visual inspection of the 5-10 mm sections harvested
from the human vessel specimens and the rabbits prior
to fixation revealed no evidence of vessel perforation,
heat injury or plaque rupture attributable to the intra-
vascular CMR detector.
Discussion
In this paper we evaluated the utility of a high-resolu-
tion (80-μm) receive-only intravascular loopless CMR
Figure 4 High resolution CMR of human iliac artery specimen acquired using the 3 T loopless CMR detector showing a fibrous cap
(arrows) at (A) 140 μm; (B) 100 μm; and (C) 80 μm resolution (here, image pixel intensity is inversely scaled to compensate for the
~1/r signal drop with distance, r, from the detector). The corresponding histological section is shown in (D).
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detector as a possible guidewire for identifying imaging
and measuring the fibrous cap thickness of atherosclero-
tic plaques in a widely-available clinical 3T MR system.
In a 1-cm region (r ≤ 5 mm), potentially relevant to
most cases of coronary and carotid vessel imaging, the
detector retains over 17% of the peak sensitivity at its
junction. Moreover its extended spatial sensitivity along
a lead length of about double the whip length (Figures
1, 2, 6), permits angiographic imaging using relatively
low-resolution coronal CMR to identify suspected ather-
osclerotic lesions, and supports a guidewire function
under CMR alone that does not require X-ray fluoro-
scopy. This strategy differs from the CMR endoscopy
approach [36,37] where the detector’s intrinsic sensitiv-
ity is limited to a thin sensitive disk by design, and the
CMR’s frame-of-reference is locked to the probe-head
to provide a “probe’s-eye view”. Here we have shown
that, after detection by low-resolution angiographic-type
CMR, suspect lesions can subsequently be targeted for
high-resolution CMR that visualizes calcifications as sig-
nal voids (Figure 3) and permits accurate characteriza-
tion of FCT (Figures 5, 6), a key predictor of plaque
vulnerability to rupture.
Although the FCT measurements were only performed
on human specimens in an electrically bio-analogous sal-
ine phantom, the feasibility of the approach was demon-
strated with a 0.76 mm maximum diameter biocompatible
nitinol loopless antenna guidewire in vivo in the rabbit
aorta (Figures 7, 8). In these studies, artifacts from respira-
tory and cardiac motion were relatively minor, perhaps
reflecting the limited spatial extent of high-resolution ima-
ging. At least motion did not seem to affect the accuracy
of measurements of aortic wall thickness or plaque size in
T2 or T1-weighted CMR, which agreed with histological
measurements to within 2% and 10%, respectively. The
scan time for 3D cardiac-gated in vivo 80 μm high-resolu-
tion CMR with the 3T loopless detector was 7-10 min
(Figures 7, 8), which is within a range that is potentially
tolerable for clinical research studies.
The improved performance of the 3T intra-vascular
loopless detector compared to prior 1.5T devices derives
from an approximately quadratic SNR performance with
MR field-strength [33]. Here, the SNR gain was exchanged
for a high-resolution intravascular imaging capability, and
a higher-speed lower-resolution angiographic-type CMR
that permitted device tracking. In addition, the extended
CMR-sensitivity of the guidewire about the cable/whip
junction obviated the need for precise device positioning
or repeated tracking-scans, enabling high-resolution ima-
ging anywhere within the detector’s sensitive region. At 80
μm resolution, the 3T loopless detector provided excep-
tional views of the vessel wall and pathology (Figures. 3, 4,
7, 8), with FCT measurements accurate to within 13 ± 9%
on average compared to histology, with which they were
strongly correlated (Figure 5). This was also true of pla-
ques with a mean FCT of less than the 650 μm threshold
for discriminating symptomatic from asymptomatic caro-
tid artery stenoses, as identified by IVUS [13]. The impli-
cation is that interventional 3T CMR with a loopless
guidewire detector could potentially do the same.
Degrading the CMR spatial resolution negatively
affected the accuracy of FCT measurements. Increasing
the voxel size from 80 μm to 140 μm resulted in an over-
estimate of 360 μm being recorded for a plaque with a
186 μm FCT measured by histology, possible distortions
introduced during histological preparation notwithstand-
ing. That an 180 μm cap is even observable with a 140 μm
voxel size attests to the high contrast sensitivity of CMR,
and again supports its potential for plaque detection at a
coarser but more time-efficient spatial resolution, followed
by high-resolution CMR for plaque characterization. Note
Figure 5 Comparison of mean FCT measured by high-
resolution intravascular 3 T CMR and by histology. The line of
best fit for all the data (n = 31) is y = 0.98 × + 11.5 μm (correlation
coefficient, R = 0.96; probability that difference in FCT is
insignificant, P = 0.99).
Figure 6 Bland-Altman plot for the mean FCT measured by
high-resolution CMR and by histology.
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also that the averaging of many measurements of FCT
from high-resolution CMR can result in reasonably accu-
rate estimates of FCT right down to the native resolution
of the scans (Figure 5).
Nevertheless, the 80 μm resolution employed here is
higher than the 65 μm FCT proposed for classifying fibrous
caps in coronary plaques as vulnerable [7-10]. In the con-
text of other intravascular imaging modalities, the CMR
resolution achieved here is comparable to the best achieved
by IVUS at around 100 μm [9,11-13]. However, as shown
in prior studies comparing CMR with IVUS [14,29], CMR
has better soft-tissue contrast and is not limited by the pre-
sence of calcifications [14,29], which were common in our
sample cohort (eg, Figure 3). We could not match OCT’s
resolution of 10-20 μm [9,10], but CMR’s FOV or
penetration depth was a good order-of-magnitude larger
than in OCT. Also, unlike either of these modalities, intra-
vascular CMR did not require X-ray fluoroscopic guidance.
Our scan-times for high-resolution CMR in the aorta were
exacerbated by the use of cardiac-gated acquisition. Intra-
vascular CMR of vessels further from the heart might ben-
efit from more-efficient steady-state sequences if gating
could be omitted. Also, the promise of a quadratically
increasing SNR afforded by even higher B0 human MR
scanners [33] offers further hope for 65 μm FCT measure-
ments and/or much shorter scan-times.
Conclusion
In conclusion, the purpose of the present work was to
establish the feasibility of 3T intravascular CMR for
Figure 7 (A) In vivo T1-weighted angiographic coronal image acquired by loopless intravascular CMR detector from a female New
Zealand white rabbit showing the aorta near the renal bifurcation. (B) X-Ray fluoroscopic image confirming placement of the loopless CMR
detector in the aorta 4 cm above the renal bifurcation. (C) The cardiac-gated 80 μm high-resolution 3 T CMR of the rabbit aortic vessel wall 1
cm above the renal bifurcation. (D) Post-mortem histological image of aortic vessel wall of the same imaging slice. The shape is distorted during
harvesting and staining processes. A small indent is evident on the vessel wall in both the image (C) and histology (D; red arrows)
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quantifying FCT and to develop a strategy for its use in
vivo. We found that a 3T loopless intravascular CMR
detector could locate atherosclerotic lesions in human
arterial specimens in vitro, accurately measure FCT at
high-resolution over a range of about 100-1000 μm, and
that the same approach is feasible in vivo. While it is
hoped that 3 T intravascular CMR may provide a useful
imaging option for quantitatively assessing vulnerable
plaque and evaluating the efficacy of therapies designed
to reduce plaque burden, further work will be required
to determine its role in the context of existing intravas-
cular imaging approaches.
Abbreviations
CMR: cardiovascular magnetic resonance; FCT: fibrous cap thickness; SNR:
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Figure 8 (A) In vivo cardiac-gated T1-weighted 80 μm resolution axial 3 T image acquired from a male hyperlipidemic rabbit aorta
showing an area of abnormal tissue extending from the inner tissue wall (red arrows), 1 cm above the renal bifurcation. (B) The
plaque region outlined from the vessel cross-section for quantification. (C) Histology of the corresponding vessel cross-section (collapsed during
processing) showing an atherosclerotic lesion (arrows) on the inner wall.
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